key: cord-0734811-t6fhx6pp
authors: Gwilym, Brenig L.; Kent, Frances; Twine, Christopher P.; Bosanquet, David C.
title: COVID-19 and abdominal aortic aneurysm intervention: when to defer and when to operate
date: 2021-06-04
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2021.05.034
sha: 12b7cac0e31a4cdf1b8d5997cd1218ca35f62f97
doc_id: 734811
cord_uid: t6fhx6pp

nan

and when to operate. 2 Brenig L. Gwilym 1 , Frances Kent 1 , Christopher P. Twine 2 , David C. Bosanquet 1 This analysis, however, is limited owing to the data on which they base annual rupture risk, 32 which we feel to be an overestimation; and their estimation of perioperative COVID-19 33 related mortality, which we feel to be an underestimation. and 32.5% for 5.5-5.9cm, 6.0-6.9cm, and ≥7cm AAAs respectively 2 . Perioperative COVID-38 19 related mortality was assumed to be equivalent to community COVID-19 mortality risk 2 . provision and effectiveness of COVID-19 low 'green pathways'. However, by providing 85 optimal strategies at differing COVID-19 transmission risk levels, ranging from 0.01% 86 (0.02% nosocomial) to 30% (60% nosocomial), clinicians can interpret the results that most 87 closely align their current local transmission risk. Units with efficient 'green pathways' could 88 use the '0.01%' transmission template as an approximation to their risk. Lastly, the model is 89

not yet validated, this should be considered when used to support clinical decision making. 90

European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms

Reassessing the Operative Threshold for Abdominal Aortic Aneurysm Repair in the Context of Coronavirus Disease

Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair

Mortality of patients with COVID-19 who undergo an elective or emergency surgical procedure: a systematic review and metaanalysis

Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial

Population-based study of